Plunkett Research Online: Mira Pharmaceuticals Inc

MIRA PHARMACEUTICALS INC (MIRA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suff.....



Mira Pharmaceuticals Inc
Ticker: MIRA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 786 432-9792
Fax:
Address: 1200 Brickell Avenue
Suite 1950 No. 1183
Miami, FL 33133 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Manufacturers - General
Drug Manufacturers
Healthcare
Contacts Description
Erez AminovCEO/Chairman of the Board/Director
Michelle YanezCFO/Chief Accounting Officer/Secretary/Treasurer
See More
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suff.....See More See More

Auditor: Cherry Bekaert LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: